$52.50
| Brand | Xerendip |
| Active ingredient |
Somatropin |
| Presentation | Solution |
| Content | 1 |
| Fraction | IV |
| Health Registration | 107M2008 SSA IV |
| Category | Super Deals |
| Subcategory | Endocrinology – Medications – Pisa |
| Tags | Pharmacy and Medical Equipment |
Xerendip 4IU (Pisa Lab) is a pharmaceutical formulation containing Somatropin, a synthetic version of human growth hormone (HGH). In clinical medicine, somatropin is prescribed to manage conditions associated with growth hormone deficiency and impaired growth. This medication is prescription-only and should be used under qualified medical supervision.
Human growth hormone is naturally produced by the pituitary gland and plays a key role in:
When natural HGH levels are insufficient, somatropin therapy may be recommended.
Somatropin-based therapies such as Xerendip 4IU (Pisa Lab) are prescribed for:
Use outside approved medical indications should only occur under medical supervision.
Somatropin mimics natural growth hormone activity by:
This helps restore normal physiological function in individuals with hormone deficiencies.
Patients should follow all prescribed instructions carefully.
Seek immediate medical attention if severe or persistent symptoms occur.
To ensure safety and effectiveness:
Somatropin products, including Xerendip 4IU (Pisa Lab), are regulated medications in most countries. Unauthorized use or distribution may be subject to legal restrictions.

















